Hannah McMellon

Hannah McMellon currently serves as the National Study Coordinator at Novo Nordisk since April 2024 and has held the position of Lead Clinical Research Coordinator at The University of Sheffield since April 2022, following nearly eleven years as a Senior Clinical Research Coordinator focused on cardiovascular clinical research. Previous experience includes serving as a Clinical Trial Practitioner at the Cancer Clinical Trials Centre, working on the 'SarCaBon' trial, and contributing as a Research Technician at Imperial College London involved in studies of RSV infections. Hannah's academic background includes a PhD in Biochemistry from The University of Sheffield and a BSc in Pharmacology from The University of Manchester. Hannah has also engaged in research on bovine respiratory disease complex and published findings on immunoregulation related to RSV vaccine-augmented lung disease.